tirzepatide injection or pill What is the Starting Dose for Weight Loss? Comparing Oral and Injectable Forms

Additionally, the introduction of Wegovy, an FDA-approved higher-dose version of Ozempic, intended to treat obesity, raises concerns about potential adverse effects

International regulatory responses further validate these concerns the European Medicines Agency required gastroparesis warnings before the FDA, while Health Canada issued safety communications about GLP-1 gastrointestinal risks, demonstrating global recognition of this serious adverse effect

Find out if youre eligible for Microdose GLP-1 Rx What is your weight loss goal

Long-term studies such as SURMOUNT-4 demonstrate that continued tirzepatide treatment helps maintain weight loss, while discontinuation typically leads to weight regain, suggesting ongoing pharmacological activity

This article examines the practical considerations, technique, and evidence surrounding thigh versus stomach injections for Wegovy, providing guidance to help patients optimise their treatment experience

As body composition shifts, there may be changes in how load is distributed across muscles and connective tissue, which can influence pelvic floor function